12749-1-AP

antibody from Proteintech Group

Targeting: ADAMTS1 C3-C5, KIAA1346, METH1

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

12749-1-AP

Provider

Proteintech Group

Product name

ADAMTS1 antibody

Antibody type

Polyclonal

Description

ADAMTS1 antibody (Cat. #12749-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Targeting ADAMTS1/HDAC6 alleviates TGF-β1/SMAD2-associated cardiac fibrosis in cardiac fibrosis post-myocardial infarction.

Jin Q, Chen C, Wu P, Li L, Jiang L, Chen R, Xu S, Huang Y, Xu H, Long X
Cell biology and toxicology 2026 Feb 12;42(1)

---

Loss of ADAMTS5 promotes vascular calcification via versican/integrin β1/FAK signal.

Zhu Z, Liu H, Feng L, Lu L, Zhu J, Liang Q, Lan Z, Ye Y, Wang S, Chen A, Yan J
Atherosclerosis 2025 May;404:119190

---

The matrix protease ADAMTS1 is transcriptionally activated by KLF6 and contributes to cardiac fibrosis in non-ischemic cardiomyopathy.

Li N, Zhu C, Xue Y, Chen N, Xu W, Song M, Qi M, Huang S, Fang M
Life sciences 2025 Jan 15;361:123295

---

Deficiency of Sox7 leads to congenital aortic stenosis via abnormal valve remodeling.

Feng W, Hong N, Wu Y, Huang J, Zhang Q, Liu G, Qian Z, Chen Y, Jin L, Ding X, Zhao P, Chen AF, Yu Y
Journal of molecular and cellular cardiology 2025 Feb;199:81-94

---

Dynamics of N6-methyladenosine modification during aging and their potential roles in the degeneration of intervertebral disc.

Liu L, Sun H, Zhang Y, Liu C, Zhuang Y, Liu M, Ai X, Long D, Huang B, Li C, Zhou Y, Dong S, Feng C
JOR spine 2024 Mar;7(1):e1316

---

Induction of A Disintegrin and Metalloproteinase with Thrombospondin motifs 1 by a rare variant or cognitive activities reduces hippocampal amyloid-β and consequent Alzheimer's disease risk.

Qiu Y, Sha L, Zhang X, Li G, Zhu W, Xu Q
Frontiers in aging neuroscience 2022;14:896522

---

Identification of polyunsaturated fatty acids related key modules and genes in metabolic dysfunction-associated fatty liver disease using WGCNA analysis.

Xiao C, Chen S, Yang C, Liu J, Yu M
Frontiers in genetics 2022;13:951224

---

Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling.

Kohsaka S, Tada Y, Ando M, Nakaguro M, Shirai Y, Ueno T, Kojima S, Hirai H, Saigusa N, Kano S, Tsukahara K, Togashi T, Ozawa H, Kondo T, Okami K, Takahashi H, Kawakita D, Fushimi C, Suzuki T, Shimizu A, Okamoto I, Okada T, Sato Y, Imanishi Y, Watanabe Y, Sakai A, Ebisumoto K, Sato Y, Urano M, Honma Y, Yamazaki K, Ueki Y, Hanazawa T, Saito Y, Shimura T, Nagao T, Mano H
NPJ precision oncology 2022 Nov 4;6(1):82